Company: CL
Filing Date: 2025-11-05
Form Type: 424B2
Source: 0001104659-25-106990
Chunk: 0

Company: COLGATE PALMOLIVE CO
Filing Date: 2025-11-05
Form: 424B2
Chunk 0
---
Filed Pursuant to Rule 424(b)(2)

Registration Statement No. 333-275201

Prospectus Supplement

(To Prospectus dated October 27, 2023)

<div align='center'>€600,000,000

3.250% Senior Notes due 2035</div>

We are offering €600,000,000 aggregate
principal amount of our 3.250% Senior Notes due 2035 (the “Notes”). Interest on
the Notes will be payable annually in arrears on November 10 of each year, commencing November 10, 2026. Unless earlier redeemed,
the Notes will mature on November 10, 2035. We may redeem the Notes
in whole or in part, at any time and from time to time, at our option, at the redemption prices described under “Description
of the Notes—Optional Redemption.” In addition, the Notes may be redeemed, at our option, in whole, but not in part, at
any time prior to maturity at a price equal to 100% of the principal amount of such Notes, together with accrued and unpaid
interest, if any, in the event of certain developments affecting United States taxation as described under “Description of the
Notes—Redemption for Tax Reasons.”

The Notes will be our senior unsecured obligations
and will rank equally in right of payment with all of our other unsecured and unsubordinated indebtedness from time to time outstanding.
The Notes will be issued only in minimum denominations of €100,000 and integral multiples of €1,000 in excess thereof.

Currently there is no public market for the Notes.
We intend to apply to list the Notes on the New York Stock Exchange (the “NYSE”). The listing application will be subject
to approval by the NYSE. If such listing is obtained, we have no obligation to maintain such listing and we may delist the Notes at any
time.

<div align='center'>Investing in the Notes involves risks. See “Risk Factors” beginning on page S-4 of this prospectus supplement and the risks discussed elsewhere or incorporated by reference in the accompanying prospectus.</div>

|          |     | Price to  |             |   |     | Underwriting |           |   |     | Proceeds, before |             |   |
|          |     | Public(1) |             |   |     | Discount     |           |   |     | Expenses, to Us  |             |   |
|